Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. - Adebowale Adeyemo, Michael Inouye, Masahiro Kanai, Kazuto Kato, Bartha M. Knoppers, Anna C. F. Lewis, Alicia R. Martin, Mark I. McCarthy, Michelle N. Meyer, Yukinori Okada, J. Brent Richards, Lucas Richter, Samuli Ripatti, Charles N. Rotimi, Saskia C. Sanderson - Dissemin

Language
Login

Published in

Nature Research, Nature Medicine, 11(27), p. 1876-1884, 2021

DOI: 10.1038/s41591-021-01549-6

Links

ORCID
Nature Research | PDF

Tools

Export citation

Search in Google Scholar

Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.

Journal article published in 2021 by Adebowale Adeyemo, Michael Inouye, Masahiro Kanai, Kazuto Kato, Bartha M. Knoppers, Anna C. F. Lewis, Alicia R. Martin, Mark I. McCarthy, Michelle N. Meyer, Yukinori Okada, J. Brent Richards, Lucas Richter, Samuli Ripatti, Charles N. Rotimi, Saskia C. Sanderson and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO